China's first infliximab biosimilar drug ready for export, Kexing Biopharm initiated drug registration in 17 countries
Kexing Biopharm won the sole agency for the first-time generic drug of infliximab, demonstrating strong superiority in international business
Kexing Biopharm released the official version of 2020 Annual Report!
Kexing Biopharm won the 14th Golden Cicada Award - Top Listed Companies with Biggest Brand Value
Open a new chapter, shape a creative future. Warm congratulations on the successful listing of Kexing Biopharm today
All contents © Copyrights 2019 Kexing Biopharm.(Lu) ICP Reg No.: 19058750
Powered by vancheer
Scan Code Consultation